What is LEVITRA (VARDENAFIL)?
LEVITRA (VARDENAFIL) is a modern medication designed for the treatment of erectile dysfunction in adult men. The active substance is vardenafil, which belongs to the group of selective phosphodiesterase type 5 inhibitors, or PDE-5 for short. Thanks to this mechanism, the drug helps improve blood flow to the cavernous bodies of the penis under the condition of sexual stimulation. Usually, LEVITRA (VARDENAFIL) is available in the form of film-coated tablets with various dosages for individual selection of therapy. The original drug is well known in clinical practice as an effective tool for restoring erectile function.
The pharmacological group of PDE-5 inhibitors combines agents that affect vascular tone in the tissues of the penis. LEVITRA (VARDENAFIL) does not cause an erection on its own: natural sexual arousal is required for a full effect. The drug acts locally in the area of increased enzyme activity, so the systemic effect on other vessels is usually moderate. The tablet form ensures convenience of administration and predictable bioavailability. Before starting use, a doctor's consultation is absolutely necessary, as the body's reaction can be individual.
In medical practice, LEVITRA (VARDENAFIL) is considered as one of the options for starting and maintenance therapy of erectile disorders. The manufacturer of the classic original product is traditionally associated with high standards of quality and control. The category of the agent is drugs for the treatment of erectile dysfunction. It is important to understand that self-medication without examination can be dangerous, especially in the presence of cardiovascular diseases. The individual reaction to vardenafil depends on age, concomitant conditions, and concomitant drug therapy.
What is LEVITRA (VARDENAFIL) prescribed for?
The main indication for the use of LEVITRA (VARDENAFIL) is erectile dysfunction — the persistent inability to achieve or maintain an erection sufficient for sexual intercourse. This condition can be associated with vascular, neurological, hormonal, or psychogenic factors. The drug helps restore the physiological mechanism of filling the cavernous tissue with blood. The doctor evaluates the causes of the disorder and determines whether vardenafil is suitable in a specific clinical situation. Without sexual stimulation, the expected effect will not occur.
LEVITRA (VARDENAFIL) is also considered in patients in whom erectile dysfunction is combined with diabetes mellitus or metabolic syndrome, provided there are no contraindications. In such cases, vascular changes often worsen the quality of erection, and the PDE-5 inhibitor can become part of a comprehensive correction. The drug does not cure the underlying disease but improves the functional outcome. It is important to monitor glucose levels, blood pressure, and overall heart condition. Any prescription must be based on an examination and risk analysis.
Separately, a doctor may recommend LEVITRA (VARDENAFIL) to men after certain urological interventions or in the presence of a psychogenic component of the disorder, when pharmacological support is needed. The goal of therapy is to restore confidence and a physiological response to arousal, rather than to replace a full examination. The drug is not intended to increase libido as an independent goal and is not an aphrodisiac in the classic sense. Before starting a course, serious organic causes of impotence should be ruled out. Consultation with a specialist remains a mandatory condition for a safe start.
Composition and active components of LEVITRA (VARDENAFIL)
The active component of LEVITRA (VARDENAFIL) is vardenafil, usually in the form of hydrochloride. It is this substance that blocks the phosphodiesterase type 5 enzyme, which breaks down cyclic guanosine monophosphate in the smooth muscles of the penile vessels. When cGMP levels rise, the vessels relax, blood flow increases, and an erection is formed in the presence of stimulation. The dosage of vardenafil in the tablet determines the intensity and duration of the response. The mechanism is reversible and depends on natural arousal signals.
In addition to the active substance, the composition includes auxiliary components: fillers, binders, coating components, and substances that improve tablet disintegration. They do not have an independent therapeutic effect but ensure the stability, taste, and technological properties of the drug. The quality of auxiliary substances affects the rate of vardenafil release in the gastrointestinal tract. In people with hypersensitivity to any ingredient, intolerance reactions are possible. Therefore, before taking, you should carefully read the composition in the instructions.
The pharmacodynamics of LEVITRA (VARDENAFIL) explain why the effect occurs relatively quickly and why it lasts for several hours. Vardenafil selectively affects PDE-5, minimizing the effect on other isoforms of the enzyme compared to less selective compounds. This is important for the tolerability profile. The individual response of the body may vary depending on liver metabolism and concomitant medications. You should not change the composition or divide tablets on your own without a doctor's recommendation.
Dosage of LEVITRA (VARDENAFIL)
For most adult men, the starting dose of LEVITRA (VARDENAFIL) is often considered to be 10 mg, taken as needed before anticipated sexual activity. Depending on efficacy and tolerability, the doctor may reduce the dose to 5 mg or increase it to 20 mg. The maximum recommended frequency is usually no more than one dose per day. The duration of the "course" is determined not by the calendar, but by the need and clinical response, but regular monitoring of the condition is mandatory. Dose adjustment is required for liver function impairment, in elderly patients, and with simultaneous use of certain enzyme inhibitors.
In patients with moderate hepatic impairment or those taking drugs that slow down the metabolism of vardenafil, the starting dose is often reduced. In old age, pharmacokinetics can change, so the approach should be more cautious. LEVITRA (VARDENAFIL) is not intended for daily uncontrolled use "just in case". If there is no effect after several attempts against the background of proper intake and stimulation, a repeated consultation is required, rather than an independent dose increase. Exceeding the recommended amount increases the risk of side reactions.
The duration of action and time to onset of effect vary, so the doctor explains realistic expectations. Sometimes episodic use is sufficient, sometimes the dynamics are evaluated over several weeks of observation. It is important not to combine different PDE-5 inhibitors on the same day. Any changes to the regimen must be agreed with a specialist. The individual reaction of the body means that the same dose can act differently in different patients.
How to take LEVITRA (VARDENAFIL) correctly?
LEVITRA (VARDENAFIL) is taken orally, washed down with a sufficient amount of water, usually 25–60 minutes before expected sexual activity. The tablet is swallowed whole, without chewing, unless otherwise specified in the instructions for the specific form. Fatty food can slow down absorption and delay the onset of action, so a heavy meal immediately before use is undesirable. Alcohol in large quantities worsens erection and increases the likelihood of dizziness. The drug works only in the presence of sexual stimulation.
If a dose is missed, the next dose is not doubled: LEVITRA (VARDENAFIL) is used as needed, and not on a strict hourly schedule like antibiotics. You should not take a repeated tablet within the same day without direct instructions from a doctor. The patient should discuss in advance how to behave in case of concomitant diseases and which symptoms require immediate help. Keep an interval between doses and avoid combination with other erection stimulants. Before starting therapy, consultation with a doctor is mandatory.
Warnings also apply to situations with a sudden drop in blood pressure, chest pain, or visual impairment. In such cases, use is discontinued and medical help is sought. It is not recommended to experiment with the time of intake or crushing tablets without professional advice. Compliance with the instructions increases the predictability of the result. Remember: efficacy and safety depend on proper use and individual characteristics of the body.
Side effects of LEVITRA (VARDENAFIL)
Common side effects of LEVITRA (VARDENAFIL) include headache, flushing of the face, nasal congestion, and dyspepsia. They are associated with vasodilation and usually resolve on their own. Some men report dizziness or mild color vision impairment. The intensity of reactions depends on the dose and sensitivity. If symptoms are pronounced or recur, a doctor's evaluation is needed.
Uncommon reactions may include increased or decreased blood pressure, drowsiness, muscle and back pain, and palpitations. Less frequently described are allergic manifestations, vision changes, ringing in the ears, or prolonged erection. Priapism — an erection lasting more than four hours — requires emergency assistance, as it threatens the tissues of the penis. Any sudden chest pain during intimacy is a reason to stop activity and seek help. Do not ignore unusual neurological or ophthalmic symptoms.
You should contact a doctor immediately if there are signs of a severe allergy, sharp deterioration of vision or hearing, fainting, or severe pain. Even "habitual" side effects that do not go away require dose adjustment or a change in tactics. Continuing to take the drug on your own against the background of poor tolerability is dangerous. The safety profile of LEVITRA (VARDENAFIL) has been studied, but an individual reaction of the body is always possible. Regular feedback with the doctor helps minimize risks.
Contraindications of LEVITRA (VARDENAFIL)
Absolute contraindications to LEVITRA (VARDENAFIL) are the simultaneous use of nitrates and nitric oxide donors, as the combination can cause a sharp drop in blood pressure. The drug is not used in case of hypersensitivity to vardenafil or auxiliary substances. Severe forms of cardiovascular failure, recent myocardial infarction or stroke, unstable angina, and conditions in which sexual activity is contraindicated also exclude self-use. The agent is usually not prescribed to patients with severe hepatic impairment or certain hereditary degenerative diseases of the retina. The decision is always made by a doctor after assessing the risks.
Relative contraindications include anatomical deformations of the penis, predisposition to priapism, bleeding disorders, active peptic ulcer disease, and moderate liver or kidney function impairment. In such situations, use is possible only under strict control and in an adapted dose. LEVITRA (VARDENAFIL) is not intended for women, including during pregnancy and lactation, and is not used in pediatrics. For elderly men, caution is required due to concomitant pathology and polypragmasy. The drug is categorically not indicated for adolescents and children.
Special attention is paid to patients taking alpha-blockers or potent CYP3A4 inhibitors. Before prescription, exercise tolerance and the state of coronary vessels are evaluated. The presence of contraindications is not always obvious without an examination, so self-diagnosis is unacceptable. Consultation with a doctor before taking LEVITRA (VARDENAFIL) is mandatory. The individual reaction of the body can change the benefit-risk ratio even in the formal absence of prohibitions.
Interaction of LEVITRA (VARDENAFIL) with other drugs and alcohol
LEVITRA (VARDENAFIL) has clinically significant interactions with nitrates, certain antiarrhythmic agents, potent antifungal and antiretroviral drugs, as well as with individual macrolide antibiotics. CYP3A4 isoenzyme inhibitors increase the concentration of vardenafil in the blood, which enhances side effects. Alpha-blockers can cumulatively lower blood pressure, so the combination is agreed upon and separated in time. Different PDE-5 inhibitors must not be combined. The full list of concomitant medications should be reported to the doctor before starting therapy.
Alcohol in moderate amounts formally does not cancel the effect of the drug, but large doses worsen erection, increase dizziness and hypotension. Driving and operating machinery require caution until the individual response to LEVITRA (VARDENAFIL) is determined, especially if visual disturbances or drowsiness occur. On the day of intake, it is better to assess how you feel before driving. A safe combination with chronic medications is possible only after a professional evaluation. Always inform your doctor about any changes in your treatment regimen.
Where to buy LEVITRA (VARDENAFIL) in Ukraine
LEVITRA (VARDENAFIL) is available in the pharmacy network of Ukraine by doctor's prescription, and can also be offered through licensed online pharmacies with delivery in accordance with current regulations. You should buy only in verified places to avoid counterfeits and violations of storage conditions. Store tablets in the original packaging, in a dry place at room temperature, out of reach of children, protected from excessive heat and moisture. Before use, check the expiration date and the integrity of the blister. Delivery of prescription drugs is carried out in compliance with pharmaceutical requirements.
When choosing a dose and form, it is important to rely on the specialist's prescription, rather than on advertising promises. Consultation with a doctor before taking LEVITRA (VARDENAFIL) helps evaluate indications, rule out contraindications, and select a safe regimen. The individual reaction of the body to vardenafil may vary, so monitoring how you feel after the first doses is especially important. Do not replace professional diagnostics with self-selection "based on reviews". A quality drug and competent medical support are the basis of effective and safe therapy for erectile dysfunction.
Free delivery from UAH 1000
Across Ukraine
















